Taylor M D, Perry J, Zlatescu M C, Stemmer-Rachamimov A O, Ang L C, Ino Y, Schwartz M, Becker L E, Louis D N, Cairncross J G
Department of Medicine, University of Toronto, Ontario, Canada.
J Neurosurg. 1999 May;90(5):946-50. doi: 10.3171/jns.1999.90.5.0946.
Patients with Turcot syndrome (TS) are predisposed to colon tumors and primary brain tumors, typically glioblastomas or medulloblastomas. The authors describe a patient with TS featuring a known germline mutation of exon 5 of the hPMS2 mismatch repair gene who developed two metachronous glioblastomas, both with distinct oligodendroglial features. Molecular genetic analysis revealed allelic loss of chromosome 19q in the patient's second tumor but no allelic loss of chromosome 1p. Prominent microsatellite instability was also found in this tumor, consistent with a germline mismatch repair defect. Because this patient had an unusual underlying condition and his tumor had a unique histological appearance for TS, it was hypothesized that this genetic defect may predispose to malignant gliomas with oligodendroglial features. The authors therefore evaluated whether sporadic glioblastomas and oligodendrogliomas undergo mutations of this region of the hPMS2 gene. However, single-strand conformation polymorphism analysis of hPMS2 exon 5 failed to reveal mutations in 20 sporadic glioblastomas and 16 sporadic oligodendroglial gliomas. Thus, although it is possible that the germline hPMS2 exon 5 mutation may predispose to glioblastomas with an oligodendroglial component, the same genetic defect is not commonly involved in sporadic oligodendrogliomas or glioblastomas.
Turcot综合征(TS)患者易患结肠肿瘤和原发性脑肿瘤,通常为胶质母细胞瘤或髓母细胞瘤。作者描述了一名患有TS的患者,其hPMS2错配修复基因第5外显子存在已知的种系突变,该患者发生了两个异时性胶质母细胞瘤,二者均具有明显的少突胶质细胞特征。分子遗传学分析显示,该患者的第二个肿瘤存在19号染色体长臂等位基因缺失,但不存在1号染色体短臂等位基因缺失。在该肿瘤中还发现了明显的微卫星不稳定性,这与种系错配修复缺陷一致。由于该患者有不寻常的基础疾病,且其肿瘤具有TS独特的组织学表现,因此推测这种基因缺陷可能易患具有少突胶质细胞特征的恶性胶质瘤。因此,作者评估了散发性胶质母细胞瘤和少突胶质细胞瘤是否发生hPMS2基因该区域的突变。然而,对hPMS2第5外显子进行单链构象多态性分析,未能在20例散发性胶质母细胞瘤和16例散发性少突胶质细胞瘤中发现突变。因此,尽管种系hPMS2第5外显子突变可能易患具有少突胶质细胞成分的胶质母细胞瘤,但散发性少突胶质细胞瘤或胶质母细胞瘤通常不涉及相同的基因缺陷。